somerset, wiltshire, avon and gloucestershire (swag ... ?· somerset, wiltshire, avon and...

Download Somerset, Wiltshire, Avon and Gloucestershire (SWAG ... ?· Somerset, Wiltshire, Avon and Gloucestershire…

Post on 11-Jun-2018

213 views

Category:

Documents

0 download

Embed Size (px)

TRANSCRIPT

  • South West Strategic Clinical Network Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services

    Version 1.0 1 SSG Annual Report

    Somerset, Wiltshire, Avon and Gloucestershire (SWAG)

    Cancer Services

    Haematology Cancer Network Site Specific Group

    Annual Report

    2014

  • South West Strategic Clinical Network Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services

    Version 1.0 2 SSG Annual Report

    This annual report was prepared by:

    Sophie Otton Chair of the SWAG Haematology SSG

    Helen Dunderdale SWAG Cancer Network SSG Support Manager

    This annual report has been agreed by:

    Name Position Organisation Date Agreed

    Christopher Knechtli Consultant Haematologist Royal United Hospital

    Bath NHS Foundation

    Trust

    May 2015

    Deepak Mannari Consultant Haematologist Taunton and Somerset

    NHS Foundation Trust

    & Yeovil Hospitals

    Foundation Trust

    May 2015

    Stephen Robinson Consultant Haematologist University Hospitals

    Bristol NHS Foundation

    Trust

    May 2015

    Anna Morris Consultant Haematologist Weston Area Health Trust May 2015

  • South West Strategic Clinical Network Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services

    Version 1.0 3 SSG Annual Report

    Haematology NSSG Annual Report Contents

    Section Contents Measures Page

    1 Overview, achievements and challenges

    1.1 Overview of report 4

    1.2 Overview of service 4

    1.3 Achievements and key service improvements over the past 12 months

    4

    1.4 Challenges for the SSG moving forward

    5

    2 The Network Group Meeting and membership

    13-1C-103h

    2.1 Chair of the SSG 5

    2.2 Network Group Membership 13-1C-102h 5

    2.3 Attendance Spreadsheet 5

    2.4 Extended Members of the SSG 7

    2.5 Network Group Quoracy 7

    3 Service Development 13-1C-104h

    3.1 The National Cancer Survivorship Initiative

    8

    3.2 The function of the SSG meeting

    8

    4 Chemotherapy Treatment Algorithms

    13-1C-108h 8

    5 Patient Experience 13-1C-111h

    5.1 User Involvement 8

    5.2 The National Cancer

    Experience Survey

    9

    6 Clinical Outcome

    Indicators and Audits

    13-1C-112h

    6.1 Network Audits 10

    6.2 Clinical quality indicators 10

    7 Research

  • South West Strategic Clinical Network Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services

    Version 1.0 4 SSG Annual Report

    7.1 Discussion of Clinical Trials 13-1C-113h 10

    7.2 Recruitment Action Plan 10

    7.3 Current Clinical Trials Activity 11

    7.4 Recruitment of Teenagers and Young Adults

    14

    1. Overview, achievements and challenges

    1.1 Overview of report

    This report reflects the period of activity for the SSG from 1st January 2014 to 31st December 2014. It

    contains a summary of the activity of the Haematology SSG for this period against several key

    performance indicators that have been outlined in the National Cancer Peer Review Programme.

    The report should be reviewed alongside three other key documents for the SSG: the Constitution,

    Clinical Guidelines and the Work Programme. The Haematology SSG Constitution provides an

    overview of how the SSG operates, outlining the general working processes of the SSG, the patient

    referral pathways and the guidelines to which the SSG adheres. The investigational and clinical

    guidelines outline the diagnostic and treatment processes agreed by the network group. The Work

    Programme summarises the key areas for growth, development and improvement of the SSG over

    the next financial year (and beyond where appropriate). All four documents should be reviewed

    together to give a full overview of the SSG, its performance and future plans.

    1.2 Overview of service

    The Haematology site-specific group aims to oversee, support and bring together the viewpoints of

    all the multi-disciplinary teams working within the haematological cancer services across the

    Network. The group also aims to ensure the same standard of care and treatment with this type of

    cancer across the Network. The SSG also serves to ensure implementation of NICE guidelines for

    investigation and treatment of Haematological cancers and to provide guidelines for supportive care.

    The group undertakes the process of protocol development and review. It supports a programme of

    education on key developments in the field of Haematological cancer. It also aims to continue and

    expand the clinical trials programmes available within individual trusts.

    1.3 Achievements and key service improvements over the past 12 months

    The following are noted as key achievements and service improvement of the Haematology SSG over

    the past 12 months (during 2014).

    The SSG has undergone reconfiguration in line with the national cancer clinical networks,

    incorporating Gloucester and Cheltenham NHS Trust.

    The SSG has undertaken a major review of chemotherapy protocols in 2014.

    The SSG has appointed a new patient representative.

    The SSG has engaged in an educational programme.

    The SSG has conducted a clinical audit.

  • South West Strategic Clinical Network Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services

    Version 1.0 5 SSG Annual Report

    1.4 Challenges for the SSG moving forward

    The key challenges for the Haematology SSG moving forward have been highlighted below.

    Ensuring the SWAG website is fully functional, with all currently used chemotherapy

    protocols available.

    Ensuring implementation of NICE guidance on investigational pathways.

    Ensuring that all Trusts in the Network regularly contribute to the educational and audit

    programmes.

    Continuing to expand and support the clinical trials programme with both late and early

    phase trials.

    2. The NSSG Meeting and Membership (measure 13-1C-102h)

    2.1 Chair of the SSG

    Dr Sophie Otton has been the Chair of the Haematology SSG since 2012. A list of responsibilities for

    the SSG, for the Chair, and other members of the SSG, plus the SSG terms of reference, can be

    found in the paper Recurrent Arrangements for Cancer Network Clinical Groups and

    Responsibilities for Peer Review, as proposed by the South West Strategic Clinical Network

    (SCRN) Cancer Network Manager, Jonathan Miller (14th July 2014):

    http://www.swscn.org.uk/wp/wp-content/uploads/2014/08/Cancer-Network-Clinical-Groups-

    Recurrent-Arrangements-v5-Final.pdf

    The NSSG meetings are also conducted in line with the Manual for Cancer Services,

    Haematology Measures (Version 1.0):

    2.2 Network Group Membership (measure 13-1C-103h)

    The Haematology SSG is held approximately every five months. In 2014, meetings were held on the

    10th June 2014 and the 14th October 2014.

    The table below shows the core members of the SSG and their attendance.

    All participants at MDTs are welcome to attend the SSG meetings.

    Table 1.0 Haematology SSG core members and attendance

    Name Position Trust 10/06/2014 14/10/2014

    Sophie Otton Consultant Haematologist

    North Bristol Trust (NBT)

    Deepak Mannari Consultant Haematologist

    Taunton and Somerset NHS Foundation Trust (TST) & YDH

    http://www.swscn.org.uk/wp/wp-content/uploads/2014/08/Cancer-Network-Clinical-Groups-Recurrent-Arrangements-v5-Final.pdfhttp://www.swscn.org.uk/wp/wp-content/uploads/2014/08/Cancer-Network-Clinical-Groups-Recurrent-Arrangements-v5-Final.pdf

  • South West Strategic Clinical Network Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services

    Version 1.0 6 SSG Annual Report

    Christopher Knechtli

    Consultant Haematologist

    Royal United Hospitals Bath NHS Foundation Trust (RUH)

    Stephen Robinson

    Consultant Haematologist

    University Hospitals Bristol NHS Foundation Trust (UH Bristol)

    Anna Morris Consultant Haematologist

    Weston Area Health NHS Trust (WAHT)

    Jenny Bird

    Consultant Haematologist and Clinical Director of Oncology

    University Hospitals Bristol NHS Foundation Trust (UH Bristol)

    Matthew Beasley

    Consultant Oncologist

    University Hospitals Bristol NHS Foundation Trust (UH Bristol)

    Samreen Siddiq Consultant Haematologist

    North Bristol Trust

    Lisa Lowry Consultant Haematologist / Research Lead

    University Hospitals Bristol NHS Foundation Trust (UH Bristol)

    James Griffin Consultant Haematologist

    University Hospitals Bristol NHS Foundation Trust (UH Bristol)

    Sally Moore Consultant Haematologist / Research Lead

    Royal United Hospitals Bath NHS Foundation Trust (RUH)

    Julian Kabala Consultant Radiologist

    University Hospitals Bristol NHS Foundation Trust (UH Bristol)

    Becky Bagnall Consulant Pharmacist

    North Bristol Trust (NBT)

    Georgina Holmes

    Consultant Pharmacist

    University Hospitals Bristol NHS Foundation Trust (UH Bristol)

    Andrea Preston Consultant Pharmacist

    University Hospitals Bristol NHS Foundation Trust (UH Bristol)

    Gwenda Morgan Clinical Nurse Specialist

    Weston Area Health NHS Trust (WAHT)

    Graeme Butters Clinical Nurse Specialist

    North Bristol Trust (NBT)

  • South West Strategic Clinical Network Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services

Recommended

View more >